OpenURL Connection Search

Select item for more details and to access through your institution.

Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs.
Published in:
Emerging Infectious Diseases, 2024, v. 30, n. 11, p. 2227, doi. 10.3201/eid3011.231416
By:
- Ghosh, Mayurika;
- Iarikov, Dmitri;
- Xiaojing (Karen) Qi;
- Rubin, Daniel;
- Shurland, Simone;
- Goodwin, Avery;
- Xiaohui Wei;
- Chilukuri, Dakshina;
- McMaster, Owen;
- Miller, Terry;
- Kim, Peter;
- Sherwat, Adam
Publication type:
Article
The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.
Published in:
Clinical Infectious Diseases, 2015, v. 61, p. S32, doi. 10.1093/cid/civ460
By:
- Chilukuri, Dakshina;
- McMaster, Owen;
- Bergman, Kimberly;
- Colangelo, Philip;
- Snow, Kerry;
- Toerner, Joseph G.
Publication type:
Article
Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development.
Published in:
Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1564, doi. 10.1093/cid/ciad607
By:
- Jjingo, Caroline J;
- Bala, Shukal;
- Waack, Ursula;
- Needles, Mark;
- Bensman, Timothy J;
- McMaster, Owen;
- Smith, Thomas;
- Blakely, Brandon;
- Chan, Irene Z;
- Puthawala, Khalid;
- Dixon, Cheryl;
- Kim, Yongman;
- Lim, Robert;
- Colangelo, Philip;
- Clair, Christopher St.;
- Nambiar, Sumathi;
- Moss, Richard B;
- Botgros, Radu;
- Bazaz, Rohit;
- Denning, David W
Publication type:
Article
Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults.
Published in:
Journal of Infectious Diseases, 2024, v. 230, n. 2, p. 505, doi. 10.1093/infdis/jiae146
By:
- Smith, Heidi L;
- Bensman, Timothy J;
- Mishra, Shrimant;
- Li, Xianbin;
- Dixon, Cheryl A;
- Sheikh, Jalal;
- McMaster, Owen G;
- Joshi, Abhay;
- Rubin, Daniel B;
- Goodwin, Avery;
- Miller, Terry J;
- Danielsen, Zhixia Y;
- Syed, Irum;
- Shukla, Sunita J;
- Iarikov, Dmitri;
- Kim, Peter W;
- Farley, John J
Publication type:
Article

Found: 4

Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs.

The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.

Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development.

Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults.